Skip to main content

Advertisement

Log in

Comorbidity burden and health-related quality of life in men with advanced prostate cancer

  • Research
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Identifying clinically relevant comorbidities and their effect on health-related quality of life (HRQoL) outcomes among men with advanced prostate cancer (APC) can inform patient care and improve outcomes; however, this is poorly understood. The aim of this observational study was to examine the prevalence of comorbidities, and the relationship of comorbidity burden to HRQoL and other patient-reported outcomes (PROs) among men with APC.

Methods

Participants were 192 men (average age 68.8) with APC (stage III or IV) who completed a psychosocial battery including measures of sociodemographic factors, HRQoL and other PROs, and the Charlson Comorbidity Index (CCI). Hierarchical multiple regression analysis was used to examine the relationships between CCI, HRQOL, and PROs.

Results

The vast majority (82%) of participants had at least one comorbidity, with the most common being: hypertension (59%), connective tissue disease or arthritis (31%), diabetes (24%), and problems with kidneys, vision, or another organ (24%). After controlling for covariates, regressions showed that a higher CCI score was significantly associated with worse HRQoL (p < 0.001), lower levels of positive affect (p < 0.05), and higher levels of depression (p < 0.05), fatigue (p < 0.001), pain (p < 0.01), stress (p < 0.01), and cancer-specific distress (p < 0.05).

Conclusions

Comorbidities were common among men with APC, and a greater CCI score was associated with detriments in several domains of HRQoL and other PROs. Our findings show the need to address comorbidities in the presence of a cancer diagnosis and subsequent treatment.

Trial registration clinicalTrials.gov identifier

NCT03149185.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data are currently used for secondary analyses and manuscript development. The data that support the study may be available upon request with permission from the researchers who collected the data.

References

  1. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database, Cancer Stat Facts: Prostate Cancer. 2017-2018, National Cancer Institute (NCI),: Online www.seer.cancer.gov

  2. SEER (n.d.) Cancer stat facts: prostate cancer. National Cancer Institute, Bethesda, MD. https://seer.cancer.gov/statfacts/html/prost.html

  3. Droz JP et al (2010) Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 106(4):462–469

    Article  PubMed  PubMed Central  Google Scholar 

  4. Michaelson MD et al (2008) Management of complications of prostate cancer treatment. CA Cancer J Clin 58(4):196–213

    Article  PubMed  PubMed Central  Google Scholar 

  5. Spratt DE et al (2021) Treating the patient and not just the cancer: therapeutic burden in prostate cancer. Prostate Cancer Prostatic Dis 24(3):647–661

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rawla P (2019) Epidemiology of Prostate Cancer. World journal of oncology 10(2):63–89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bernard B et al (2020) Impact of age at diagnosis of de novo metastatic prostate cancer on survival. Cancer 126(5):986–993

    Article  PubMed  Google Scholar 

  8. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34

    Article  PubMed  Google Scholar 

  9. Divo MJ, Martinez CH, Mannino DM (2014) Ageing and the epidemiology of multimorbidity. Eur Respir J 44(4):1055–1068

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ward BW, Schiller JS, Goodman RA (2014) Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 11:E62

    Article  PubMed  PubMed Central  Google Scholar 

  11. Koroukian SM, Murray P, Madigan E (2006) Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol 24(15):2304–2310

    Article  PubMed  Google Scholar 

  12. Chamie K et al (2012) Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med 27(5):492–499

    Article  PubMed  Google Scholar 

  13. Matthes KL et al (2018) Impact of comorbidities at diagnosis on prostate cancer treatment and survival. J Cancer Res Clin Oncol 144(4):707–715

    Article  PubMed  Google Scholar 

  14. Daskivich TJ et al (2013) Effect of age, tumor risk, and comorbidity on competing risks for survival in a US population-based cohort of men with prostate cancer. Ann Int Med 158(10):709–717

    Article  PubMed  Google Scholar 

  15. Daskivich T et al (2010) Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med 170(15):1396–1397

    Article  PubMed  Google Scholar 

  16. Fortin M et al (2004) Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2(1):51

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wen W et al (2021) Racial disparities in mortality for patients with prostate cancer after radical prostatectomy. Cancer 127(9):1517–1528

    Article  PubMed  Google Scholar 

  18. Price JH et al (2013) Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States. Biomed Res Int 2013:787616–787616

    Article  PubMed  PubMed Central  Google Scholar 

  19. Penedo FJ et al (2020) Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial. Int J Behav Med 27(5):490–505

    Article  PubMed  PubMed Central  Google Scholar 

  20. Penedo FJ et al (2021) Effects of web-based cognitive behavioral stress management and health promotion interventions on neuroendocrine and inflammatory markers in men with advanced prostate cancer: A randomized controlled trial. Brain Behav Immun 95:168–177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Benzo RM, Moreno PI, Noriega-Esquives B, Otto AK, Penedo FJ (2022) Who benefits from an eHealth-based stress management intervention in advanced prostate cancer? Results from a randomized controlled trial. Psycho-oncology 31(12):2063–2073. https://doi.org/10.1002/pon.6000

    Article  PubMed  Google Scholar 

  22. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–98

    Article  CAS  PubMed  Google Scholar 

  23. Sun L et al (2021) Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer. JAMA Netw Open 4(2):e210070–e210070

    Article  PubMed  PubMed Central  Google Scholar 

  24. Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  CAS  PubMed  Google Scholar 

  25. Cella DF et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579

    Article  CAS  PubMed  Google Scholar 

  26. Cella D et al (2007) The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 45(5 Suppl 1):S3–S11

    Article  PubMed  PubMed Central  Google Scholar 

  27. Clover K et al (2018) PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients. Qual Life Res 27(5):1357–1367

    Article  PubMed  Google Scholar 

  28. Hann DM et al (1998) Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7(4):301–310

    Article  CAS  PubMed  Google Scholar 

  29. Melzack R (1987) The short-form McGill Pain Questionnaire. Pain 30(2):191–197

    Article  PubMed  Google Scholar 

  30. Kahl C, Cleland JA (2005) Visual analogue scale, numeric pain rating scale and the McGill pain Questionnaire: an overview of psychometric properties. Phys Therapy Rev 10(2):123–128

    Article  Google Scholar 

  31. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396

    Article  CAS  PubMed  Google Scholar 

  32. Weiss DS, Marmar CR (1997) The Impact of Event Scale—Revised. Assessing psychological trauma and PTSD. The Guilford Press, New York, NY, US, pp 399–411

    Google Scholar 

  33. Stanton AL et al (2005) Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 23(25):6009–6018

    Article  PubMed  Google Scholar 

  34. Bradburn NM, Noll CE (1969) The structure of psychological well-being. Aldine Pub, Chicago

  35. George D, Mallery P (2010) SPSS for Windows step by step: a simple guide and reference, 17.0 update, 10th edn. Allyn & Bacon, Boston

  36. Kim H-Y (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restorative Dentist Endodontics 38(1):52–54

    Article  Google Scholar 

  37. Jeong Y, Jung MJ (2016) Application and interpretation of hierarchical multiple regression. Orthoped Nurs 35(5):338–341. https://doi.org/10.1097/NOR.0000000000000279

    Article  Google Scholar 

  38. Xiao H et al (2013) Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data. J Registry Manag 40(4):159–164

    PubMed  Google Scholar 

  39. Chambers SK et al (2017) Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology 26(10):1576–1585

    Article  PubMed  PubMed Central  Google Scholar 

  40. Reeve BB et al (2014) Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies. BJU Int 114(6b):E74–E81

    Article  PubMed  Google Scholar 

  41. Arredondo SA et al (2006) Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: Data from CaPSURE. Urology 67(3):559–565

    Article  PubMed  Google Scholar 

  42. van Stam MA et al (2020) Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices. Eur Urol Oncol 3(1):21–31

    Article  PubMed  Google Scholar 

  43. Mazimba S, Peterson, PN (2021) JAHA spotlight on racial and ethnic disparities in cardiovascular disease. J Am Heart Assoc 10(17):e023650. https://doi.org/10.1161/JAHA.121.023650

  44. Chowdhury-Paulino IM, Ericsson C, Vince R Jr, Spratt DE, George DJ, Mucci LA (2022) Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis 25(3):397–402. https://doi.org/10.1038/s41391-021-00451-z

    Article  PubMed  Google Scholar 

  45. Borno H et al (2019) All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book 39:302–308

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the patients who participated in the study, as well as the staff who recruited patients and worked continuously on delivering and improving care.

Funding

This study was supported by a National Cancer Institute (NCI) grant (R01CA157809) awarded to Dr. Frank Penedo. Dr. Roberto Benzo was supported by an NCI Training Grant (T32CA251064). Dr. Rina Fox was supported by the NCI (K08247973). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Study design and data collection were performed by Frank Penedo, Patricia Moreno, Rina Fox, Emily Walsh, Betina Yanez, and Laura Oswald. Data analyses were performed by Roberto Benzo, Raymond Balise, and Frank Penedo. The first draft of the manuscript was written by Roberto Benzo and Carlos Silvera, and all authors commented on subsequent versions. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Frank J. Penedo.

Ethics declarations

Ethical approval

All study procedures that involved human participants were following the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study procedures were approved by the Institutional Review Board at Northwestern University.

Consent to participate

Informed consent was obtained from all individual participants in the study.

Competing interests

The authors have no conflicts of interest to disclose.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Supplementary file2 (DOCX 19 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benzo, R.M., Moreno, P.I., Fox, R.S. et al. Comorbidity burden and health-related quality of life in men with advanced prostate cancer. Support Care Cancer 31, 496 (2023). https://doi.org/10.1007/s00520-023-07962-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-07962-6

Keywords

Navigation